NCT00919230

Brief Summary

At present our current practice is to provide a course of oral iron therapy for those patients with a post-operative haemoglobin which is below normal, but not severe enough to require a blood transfusion. Such a practice is not without side effects from the iron tablets, namely ingestion, nausea, diarrhoea, constipation. There is little evidence in the literature to support the current practice of using iron, with only one small randomised trial suggesting such therapy is unnecessary. We propose to recruit 300 patients recovering from a hip fracture with a post-operative haemoglobin below 11g/l. For those patients willing to enter the study, half will be given oral iron therapy (ferrous sulphate 200mg twice daily) for one month. The haemoglobin will be checked when the patients attends the hip fracture clinic at 6 weeks after discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Jul 2004

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2004

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 12, 2009

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

December 10, 2012

Status Verified

December 1, 2012

Enrollment Period

5 years

First QC Date

June 11, 2009

Last Update Submit

December 7, 2012

Conditions

Keywords

Hip fractureiron therapyanaemia

Outcome Measures

Primary Outcomes (1)

  • 6 week hemoglobin

    6 weeks after surgery

Secondary Outcomes (1)

  • Length of hospital stay side effects of therapy mortality

    one year

Study Arms (2)

no treatment

NO INTERVENTION

no iron given

ferrous sulphate

EXPERIMENTAL

iron given

Drug: Ferrous sulphate tablets

Interventions

200mg twice daily for four weeks

ferrous sulphate

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with anaemia after surgery for a hip fracture

You may not qualify if:

  • absence of anaemia, inability to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peterborough city hospital

Peterborough, Cambs, pe67nj, United Kingdom

Location

Related Publications (1)

  • Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. J Bone Joint Surg Am. 2010 Feb;92(2):265-9. doi: 10.2106/JBJS.I.00883.

    PMID: 20124051BACKGROUND

MeSH Terms

Conditions

Hip FracturesAnemia

Interventions

ferrous sulfate

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Martyn Parker

    Peterborough Hospitals

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research fellow

Study Record Dates

First Submitted

June 11, 2009

First Posted

June 12, 2009

Study Start

July 1, 2004

Primary Completion

July 1, 2009

Study Completion

August 1, 2009

Last Updated

December 10, 2012

Record last verified: 2012-12

Locations